General Surgery

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

 

 

Division of General Surgery


Gastric Electrical Stimulation - Enterra Therapy - “Gastric Pacemaker" (Gastroparesis)


What is gastroparesis?

Gastroparesis is a chronic disorder in which food moves thought the stomach more slowly than normal. Patients with gastroparesis complain of chronic or recurrent gastrointestinal symptoms such as nausea, vomiting, abdominal pain, early satiety (they get full very soon after beginning a meal), and bloating. They may require frequent hospital admissions for severe symptoms, dehydration, and malnutrition. Symptoms may become so severe that patients may find themselves unable to work or enjoy normal activities.

How is gastroparesis diagnosed?

The diagnosis of gastroparesis is confirmed with a radioisotope gastric-emptying scan. If less than half of a slightly radioactive meal (very low and safe levels) ingested prior to this test empties from the stomach in 2 hours, then the stomach is emptying slowly. This can be due to a number of factors such as an intestinal blockage or narrowing, narcotic medication use (narcotics slow the intestine’s activity) or gastroparesis. Additional tests such as an endoscopy, an upper GI x-ray series, or an ultrasound may be helpful in confirming the diagnosis of gastroparesis.

What causes gastroparesis?

The two most common causes are gastroparesis due to diabetes and what is known as idiopathic gastroparesis. Most patients with idiopathic gastroparesis are young or middle-aged women. These patients experience symptoms and delayed gastric emptying without any other clear-cut causative medical problems.

How can gastroparesis be treated?

Conventional medical approaches to treat gastroparesis have included medications to help the stomach empty. These are called ‘prokinetic’ medications and include drugs such as erythromycin, metoclopramide, and domperidone. Unfortunately, these medications are often of minimal benefit in severe cases and many patients are unable to tolerate some of the side effects. Anti-nausea medications are also commonly used to help with symptoms. A modified diet (low fiber, low fat, small, frequent meals) can help with symptoms and nutrition and is a must before considering surgery for gastroparesis. Some patients will require supplemental feedings, either through an IV or via a tube placed into their intestines. Enterra™ Therapy is a treatment option for drug-refractory symptomatic nausea and vomiting related to gastroparesis.

What is Enterra ™ Therapy?

Enterra Therapy is a treatment option for people who suffer from chronic nausea and vomiting associated with gastroparesis of diabetic or idiopathic origin, and for whom standard medications are ineffective. Enterra Therapy involves electrical stimulation of the lower stomach with a system consisting of a generator implanted deep within the tissues of the abdomen, and two electrical leads which are implanted in the wall of the stomach. The leads are almost always implanted in the stomach using laparoscopic techniques (several very small incisions).

Most patients are admitted to the hospital on the day of their surgery and stay one night. Longer hospital stays may be necessary depending on a patient’s medical problems and whether there are any complications. Surgery takes from 1-3 hours on average and is performed under general anesthesia (the patient is totally asleep and does not feel or hear anything).

What is a gastric pacemaker?

Although commonly referred to as a ‘pacemaker’, Enterra ™ Therapy involves what is more appropriately labeled as a gastric electrical stimulator. It is often called a ‘pacemaker’ because it looks similar to the cardiac pacemakers that are used to help patients with electrical disturbances in their heart. The electrical energy delivered to the stomach during Enterra ™ Therapy is high frequency and low amplitude; generally not sufficient to make the stomach contract or even empty better in many cases.

What are the results?

In many cases, Enterra Therapy has been shown to:

  • Improve nausea and vomiting associated with diabetic and idiopathic gastroparesis
    • Abdominal pain associated with gastroparesis is often not affected by this treatment, even when symptoms such as nausea and vomiting improve
  • Improve patient’s quality of life
  • Improve nutrition in patients who are malnourished as a result of their gastroparesis
  • Improve glycemic control in Diabetics with gastroparesis

Enterra ™ Therapy is not a cure for gastroparesis, but it may help significantly with the symptoms that result from the condition. The effect varies from person to person and results are not guaranteed. Even if the treatment is working and a patient is feeling better, symptoms may still flare up from time to time. It is important for patients to continue to adhere to a gastroparesis diet (low fat, low fiber) and to carefully monitor their blood sugars if they are diabetic. Gastroparesis attacks can occasionally be triggered by infection and stress, even after the gastric electrical stimulator is working well.

What are the risks of the surgery?

Enterra ™ Therapy is generally a very safe procedure. The procedure is reversible and the generator and leads can be removed at any time if necessary.

Some of the risks include infection (which may require removal of the device), erosion of the generator through the skin, perforation or erosion of the leads through the stomach wall, bleeding, injury to the internal organs, blockage of the intestines, a blood clot in the legs or lungs, or a heart attack. There are also risks of general anesthesia. As with any other surgical procedure, there are additional risks that a surgeon and the surgical team will discuss in person prior to surgery. Because the Food and Drug Association (FDA) has designated the Enterra Therapy device as a Humanitarian Use Device (HUD), there is a special consent form and institutional review process that must be adhered to. Patients are provided the opportunity to ask any questions they may have about surgery and the Enterra Device prior to initiating therapy.

Do patients feel the electrical stimulation?

Most patients do not feel the electrical stimulation.

Can other people see the gastric electrical stimulator?

The generator is about 2 ½ inches by 2 inches by ½ inch thick. It is positioned deep under the abdominal skin, but not inside the abdominal cavity. When wearing a shirt, the device is usually not apparent to other people.

How long does the stimulator battery last?

The battery life is about 5-10 years. When the battery in the device wears out, a minor surgical procedure is required in order to replace the generator and battery.

What kinds of activities and/or treatments should patients avoid after the gastric stimulator has been implanted?

  • Patients should avoid activities that put undue stress on the implanted devices. Activities that include sudden, excessive, repetitive bending, twisting, bouncing, or stretching can cause the lead to break or dislodgement of the devices.
  • Patients should avoid rubbing or twisting the device on purpose. Patients should not dive below 33 feet of water, or enter hyperbaric (decompression) chambers.
  • Diathermy is a form of heat energy. Diathermy is often used in surgical procedures (electrocautery) and in certain colonoscopic or endoscopic procedures (polypectomy or treatment of bleeding). Patients with an implanted gastric stimulator CANNOT have any shortwave diathermy, microwave diathermy, or therapeutic ultrasonic diathermy (also known as deep heat treatment) anywhere on their body. These kinds of diathermy can permanently damage the stimulator and may cause injury as well.
  • Patients with an implanted gastric stimulator cannot have MRI’s.
  • The stimulator may interfere with other implanted devices such as an implanted defibrillator or pacemaker.
  • Patients with an implanted Enterra Therapy device need to be careful when approaching theft detector and security screening devices (such as those found in airports, libraries, and some department stores). If possible, patients are directed to go around the device. Patients are provided with a medical identification card and should ask for a manual (by hand) search. If a patient with an implanted Enterra Therapy device must go through a theft detector or screening device, he/she should approach the center of the device and walk through normally. Do not linger or lean against the screening device.
  • Pregnancy: Safety for use during pregnancy or delivery has not been established. It is possible that the side effects could be dangerous for an unborn child. It is important that women of childbearing potential use some type of birth control during this therapy. If a patient finds that she is pregnant, she should inform her obstetrician and her Enterra Therapy physician to determine the best treatment plan.

How often do patients need to be seen by the Enterra ™ implanting physician after surgery?

At the Medical College of Wisconsin, clinical protocol calls for visits at 2 weeks, 2 months, 6 months, and every year. More visits may be required in patients who are slower to respond to treatment or in patients with problems. Adjustments of the stimulator settings more often than every 6 weeks or so is not advised. It can take weeks for a particular stimulator setting to take affect. At each visit, a health care provider in the Enterra™ program will interrogate the implanted stimulator to ensure that it is still functional and the parameters are acceptable. The electrical stimulation settings can be easily adjusted in clinic using a programming device.

Providers in the surgery clinic at the Medical College of Wisconsin will manage the settings on the Enterra Therapy device. We do not manage gastroparesis or associated gastrointestinal symptoms in any other way. Patients should continue to work with their regular doctor who has managed these symptoms prior to the surgical procedure to implant the Enterra™ Therapy device. We don’t prescribe medications for nausea, for gastroparesis (prokinetic medications) or pain medications to be taken on a long-term basis.

Does insurance pay for Enterra ™ Therapy?

Many insurance companies pay for the Enterra Therapy. Our team will communicate with each patient’s insurance company to request coverage. It is possible that a patient’s insurance company may decide not to cover this procedure. Sometimes, we can help appeal this decision.

How much experience do physicians at Medical College of Wisconsin have with gastric electrical stimulation for gastroparesis?

Surgeons at the Medical College of Wisconsin have one of the largest experiences with Enterra Therapy for gastroparesis in the country with more than 60 devices placed (as of November 2011) over more than 6 years. We have presented our results at national meetings and published original scientific research studies on gastroparesis and gastric electrical stimulation in major peer-reviewed surgical journals.

  • McKenna D, Beverstein G, Gaumnitz E, Reichelderfer M, Gould JC. Gastric electrical stimulation is an effective and safe treatment for medically refractory gastroparesis. Surgery. 2008, 144(4): 566-72, discussion 572-4
  • Dholakia C, Gould JC. Robotic implantation of gastric electrical stimulation electrodes for gastroparesis. Surg Endosc. 2009; 23(3): 508-12
  • Musunuru S, Gould JC. Preoperative predictors of significant symptomatic response after one year of gastric electrical stimulation for gastroparesis. World J Surg. 2010; 34(8): 1853-1855
     

Figure 1: X-ray view of implanted system

Figure 2: Generator and leads

 

webmaster@mcw.edu
© 2014 Medical College of Wisconsin
Page Updated 10/26/2012